Susquehanna International Group’s Standard BioTools LAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-19,300
| Closed | -$24.7K | – | 13675 |
|
|
2025
Q4 | $24.7K | Buy |
19,300
+600
| +3% | +$806 | ﹤0.01% | 11918 |
|
|
2025
Q3 | $24.3K | Buy |
+18,700
| New | +$24.5K | ﹤0.01% | 12018 |
|
|
2023
Q4 | – | Sell |
-15,700
| Closed | -$45.5K | – | 12870 |
|
|
2023
Q3 | $45.5K | Buy |
15,700
+4,100
| +35% | +$10.7K | ﹤0.01% | 11341 |
|
|
2023
Q2 | $22.4K | Sell |
11,600
-71,600
| -86% | -$141K | ﹤0.01% | 11610 |
|
|
2023
Q1 | $162K | Buy |
+83,200
| New | +$164K | ﹤0.01% | 10837 |
|
|
2022
Q3 | – | Sell |
-19,100
| Closed | -$31K | – | 13706 |
|
|
2022
Q2 | $31K | Sell |
19,100
-53,300
| -74% | -$132K | ﹤0.01% | 12203 |
|
|
2022
Q1 | $260K | Sell |
72,400
-9,800
| -12% | -$33.8K | ﹤0.01% | 10611 |
|
|
2021
Q4 | $322K | Buy |
82,200
+43,500
| +112% | +$204K | ﹤0.01% | 10310 |
|
|
2021
Q3 | $255K | Sell |
38,700
-51,500
| -57% | -$339K | ﹤0.01% | 10970 |
|
|
2021
Q2 | $556K | Sell |
90,200
-395,000
| -81% | -$2.11M | ﹤0.01% | 9338 |
|
|
2021
Q1 | $2.19M | Buy |
485,200
+286,500
| +144% | +$1.57M | ﹤0.01% | 5700 |
|
|
2020
Q4 | $1.19M | Buy |
198,700
+33,300
| +20% | +$219K | ﹤0.01% | 6308 |
|
|
2020
Q3 | $1.23M | Buy |
+165,400
| New | +$1.14M | ﹤0.01% | 5620 |
|
|
2020
Q2 | – | Sell |
-11,500
| Closed | -$29K | – | 10551 |
|
|
2020
Q1 | $29K | Sell |
11,500
-10,000
| -47% | -$32.9K | ﹤0.01% | 9835 |
|
|
2019
Q4 | $75K | Sell |
21,500
-33,100
| -61% | -$116K | ﹤0.01% | 9236 |
|
|
2019
Q3 | $253K | Buy |
54,600
+38,800
| +246% | +$306K | ﹤0.01% | 8658 |
|
|
2019
Q2 | $195K | Buy |
+15,800
| New | +$201K | ﹤0.01% | 9144 |
|
|
2018
Q4 | – | Sell |
-14,900
| Closed | -$112K | – | 9494 |
|
|
2018
Q3 | $112K | Buy |
+14,900
| New | +$106K | ﹤0.01% | 8559 |
|
|
2018
Q2 | – | Sell |
-11,400
| Closed | -$67K | – | 10018 |
|
|
2018
Q1 | $67K | Buy |
11,400
+500
| +5% | +$3.28K | ﹤0.01% | 8859 |
|
|
2017
Q4 | $64K | Buy |
10,900
+600
| +6% | +$3.28K | ﹤0.01% | 8840 |
|
|
2017
Q3 | $52K | Buy |
+10,300
| New | +$43.3K | ﹤0.01% | 8529 |
|
|
2016
Q4 | – | Sell |
-17,000
| Closed | -$136K | – | 9879 |
|
|
2016
Q3 | $136K | Buy |
17,000
+2,700
| +19% | +$24.8K | ﹤0.01% | 7817 |
|
|
2016
Q2 | $129K | Buy |
+14,300
| New | +$134K | ﹤0.01% | 7902 |
|
|
2016
Q1 | – | Sell |
-11,900
| Closed | -$129K | – | 9373 |
|
|
2015
Q4 | $129K | Sell |
11,900
-49,700
| -81% | -$488K | ﹤0.01% | 8754 |
|
|
2015
Q3 | $500K | Sell |
61,600
-5,000
| -8% | -$78.7K | ﹤0.01% | 7121 |
|
|
2015
Q2 | $1.61M | Buy |
66,600
+59,600
| +851% | +$1.88M | ﹤0.01% | 5173 |
|
|
2015
Q1 | $295K | Buy |
+7,000
| New | +$277K | ﹤0.01% | 8008 |
|
|
2014
Q4 | – | Sell |
-9,100
| Closed | -$223K | – | 9872 |
|
|
2014
Q3 | $223K | Sell |
9,100
-12,600
| -58% | -$354K | ﹤0.01% | 8495 |
|
|
2014
Q2 | $638K | Sell |
21,700
-37,800
| -64% | -$1.21M | ﹤0.01% | 6998 |
|
|
2014
Q1 | $2.62M | Buy |
+59,500
| New | +$2.62M | ﹤0.01% | 3862 |
|
Other funds holding LAB
CC
MCO
LFCM
VCM
HBWM
Susquehanna International Group's LAB Position: Q1 2026 in Review
Susquehanna International Group increased its Standard BioTools (LAB) stake by 71% in Q1 2026, buying an estimated $76.8K and bringing the position to 153,343 shares worth $141K. The position accounts for ﹤0.01% of the portfolio, ranked #12077.
Susquehanna International Group first reported a position in LAB in Q4 2013 and has held it in 38 quarters since. The position peaked at $5.68M in Q1 2024. 155 funds tracked by Wall St. Rank hold LAB as of Q1 2026.
- Susquehanna International Group held 153,343 shares of Standard BioTools worth $141K as of Q1 2026.
- Susquehanna International Group bought 63,409 Standard BioTools shares in Q1 2026, an estimated $76.8K.
- Standard BioTools made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12077 holding.
- Susquehanna International Group first reported a position in Standard BioTools in Q4 2013 and has held it in 38 quarters since.
- Susquehanna International Group's Standard BioTools position peaked at $5.68M in Q1 2024.
- 155 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.